enzymatic and other intracellular antioxidant defenses against pulmonary 0, toxicity is now appreciated. Experimental animal models of increased O2 tolerance have been extensively investigated, but, as yet, there is no clinically useful means of reducing or preventing 0,-induced lung injury in humans.
Although this review article presents information on the clinical manifestations, pathology, mechanism, and prevention of pulmonary 0, toxicity, recent developments concerning the mechanisms and prevention of hyperoxic damage in animal models will be emphasized because an increased understanding of these mechanisms may lead to a more rational basis for the clinical use of O2 and the development of therapeutic measures effective in preventing or decreasing the effects of 0, toxicity. Data presented here on mechanisms of hyperoxic injury and protection are obtained from experiments done under normobaric conditions and elevated partial pressures of 0,. The reader is also referred to other reviews (4-9), where certain aspects of the subject may be covered in more detail.
Clinical Manifestations
With exposure to hyperoxia at 1 atm of pressure, the lung is the organ most severely damaged because pulmonary tissue Po, is the highest in the body. As pulmonary tissue Po, is directly determined by the alveolar Po, (lo), arterial hypoxemia does not delay the development of pulmonary 0, toxicity at 1 atm of pressure (11) . Exposure to 0, at a partial pressure in excess of 2 atm of pressure also damages the central nervous system and may result in convulsions (the Paul Bert effect) due to sharply increased brain tissue Po, (10) . The rate at which O2 toxicity develops is directly related to the partial pressure of inspired 02. Until the Apollo fire of 1967 American astronauts breathed 100% 0, at a pressure of one-third of an atmosphere without showing any sign of pulmonary 0, toxicity. Hence, a high concentration of 0, may be less damaging at high altitude where the atmospheric pressure is reduced than is the same concentration at normobaric pressure (10).
The precise concentration of 0, that is toxic to humans has, for obvious reasons, been difficult to establish. Most data regarding the tolerable limits of 0, breathing have been obtained from normal, healthy, young subjects. Thus, the effects of underlying disease and other factors such as age, nutritional status, endocrinologic status, and the history of previous exposures to oxidants or other substances that may alter protective mechanisms against 0, toxicity are largely unknown.
The onset of 0, toxicity may occur after an asymptomatic period, during which no physiologic changes are detectable. In nine young men who breathed 100% 0, for 6-12 h, no abnormality could be detected in the alveolar-arterial O2 gradient, pulmonary-artery pressure, total pulmonary resistance, cardiac output, or pulmonary extravascular water volume; in addition, there were no symptoms and no x-ray changes (12).
In conscious subjects, the earliest manifestations of 0, toxicity are symptoms of tracheobroncheal irritation like cough and substernal discomfort. The onset of symptoms of tracheobroncheal irritation, roughly 6 2 2 h after the start of 0, breathing (13), parallels the occurrence of tracheitis and decreased tracheal clearance of mucus (14) . The symptoms of this 0,-induced tracheobronchitis precede changes in pulmonary function tests, but the rate of development of these symptoms is so variable as to be a poor index of 0, tolerance.
The most widely applied index of 0, toxicity in humans has been the vital capacity (VC), as early respiratory physiologists reported that subjects who breathed 90%-100% 0, for 25-30 h had a decreased VC (13,15). In 1970 it was suggested that decreases in VC could be used to predict the onset, rate of development, and degree of severity of the toxic process in the lung caused by O2 exposure (16). Subsequently, a mathematical description was developed (17) and named the "unit pulmonary toxicity dose.'' The unit pulmonary toxicity dose is still used as a guideline for 0, exposures by the U.S. Navy (18) and others (19, 20) . Recently, however, the available data set was updated, and a quantitative statistical analysis was performed to evaluate VC as an index of pulmonary 0, toxicity (21) . As previously noted by others (4, 22) , it showed that a decrease in VC is not really an ideal index of 0, toxicity development. Accurate VC measurement requires a trained subject, is effortdependent, and does not take into account the recovery periods as during intermittent exposure; moreover, the response varies among individuals. As the index is based on the response of an individual of median susceptibility, more susceptible individuals would be at increased risk.
In four healthy subjects, decreases in vital capacity were followed by small decreases in both static compliance and carbon monoxide diffusing capacity after breathing 0.98 atm of 0, for 48 h (15).
Pulmonary physiologic changes observed and reproduced in normal subjects exposed to 0, under experimental conditions may be obscured in the clinical setting. For example, patients exposed to 100% 0, for 214.4 h, compared with a control group exposed to less than 42% 0,, had no detectable physiologic alterations after cardiac surgery (23) . Similarly, there was no evidence of pulmonary 0, toxicity, judged by respiratory function, in 41 patients having high-frequency jet ventilation of the lungs with at least 80% 0, for up to 12 days (24) . On the other hand, increased ratios of dead space to tidal volume and increased arteriovenous shunting have been reported in patients with irreversible brain damage after ventilation with 100% 0, for 40 h (25). However, the patients in this study received steroid therapy, which may have affected the outcome.
Although physiologic changes attributable to 0, breathing include decreases in VC, pulmonary compliance, and diffusing capacity, together with increases in arteriovenous shunting and ratio of dead space to tidal volume, early detection of 0, toxicity requires more sensitive and specific tests.
Using a bronchoalveolar lavage (BAL) technique in volunteers exposed to more than 95% 0, for 17 h, a significant alveolar-capillary leak expressed by the presence of increased plasma albumin and transferrin in lavage fluid was detected (26) . Similarly, increases of albumin in BAL fluid occurred in a dosedependent manner in subjects inhaling 30%-50% 0, for a mean of 45 h (27) . In the same study, clearance of inhaled technetium-labeled diethylenetriamine pentaacetate, a measure of lung epithelial permeability, was increased in subjects inhaling 50% 0,. Quantitation of hydrocarbons such as pentane or ethane in expired alveolar gas is another development of possible indices of early oxidant damage. Because ethane and pentane are volatile hydrocarbons formed during free-radical-induced lipid peroxidation, the presence of these gases indicates ongoing free radical formation in lung tissue (28) . Although in humans pentane production increases within 3CL120 min of breathing 100% 0, (29), a dose relationship between inspired 0, concentration and ethane or pentane excretion is 1990; 70:195207 not yet established. In the future, it may be possible to develop a metabolic index for detection of hyperoxic pulmonary damage. The fact that the lungs' ability to metabolize biogenic amines, polypeptides, and prostaglandins (30-32) decreases soon after hyperoxic exposure might also be used to develop an "early warning" test of 0, toxicity. To date, use of the tests described above to detect pulmonary 0, toxicity in the clinical setting in an early phase has been limited for reasons including lack of specificity, problems with reproducibility, and the need for sophisticated equipment.
The above studies, however, do indicate that although early (reversible) physiologic, anatomic, and biochemical changes can be detected after short exposure to hyperoxia using sensitive tests, humans can tolerate 100% 0, at sea level for 24-48 h without serious pulmonary injury. Pulmonary damage results only with longer periods of exposure in normal subjects (but pulmonary tolerance to hyperoxia may be altered by the underlying disease and other physiologic factors). Inspired 0, in concentrations of 50%-100% over longer periods of time cames a risk of lung damage, and the duration of exposure required to produce damage seems to be proportional to the concentration of inspired 0,. The "safe" level of inspired 0, is not established, but we know that less than 50% 0, can be tolerated for extended periods of time without serious deleterious effects (4).
Pathology of Pulmonary Oxygen Toxicity
Most studies of pulmonary 0, toxicity, including ultrastructural morphometry, have been conducted in experimental animals. Few studies have been performed in human subjects; those that have been done have typically been done at autopsy after severe illnesses requiring high concentrations of 0, (usually delivered by mechanical ventilation). Consequently, although the details and time-course of pulmonary 0, toxicity are well documented in experimental animals, only the end stages of 0, toxicity have been studied in humans. However, the sequence of morphologic changes that occurs in the lungs in response to pulmonary 0, toxicity seems to be quite similar in different animal species (4,33-36) and in humans (37) , but the duration and relative severity of each phase of the process show species variability.
In most species, exposure to 100% 0, at 1 atm for 24-72 h is associated with an initial phase of injury during which no significant evidence of morphologic injury is apparent. This phase is characterized by augmentation in the production rates of partially reduced 0, species (38) due to increased intracellular metabolism of O2 (39) . These free radicals are associated with alterations in cell metabolism that are not initially associated with changes in lung structure or ultrastructure.
The earliest morphologic changes seen in the inflammatory phase involve subtle changes in endothelial cell structure that result in pericapillary accumulation of fluid (33, 37, 40) . This stage of lung injury is associated with, or rapidly followed by, accumulation of thrombocytes, macrophages, and neutrophils in the lung and the release of soluble mediators of inflammation (4043).
After exposure of rats to 0, for 36 h neutrophils are rapidly recruited to the lung (43), and after 48 h the volume of platelets retained in the pulmonary capillary bed almost doubles (41) . The appearance of neutrophils in the lung is associated with a rapid increase in the extent of morphologic lung injury (33, 40) . Neutrophils probably initiate the final stage of lethal pulmonary 0, toxicity by releasing further mediators of inflammation and, once activated, by producing toxic O2 species via oxidases on their plasma membranes (7,44). Recently it was suggested that one of these mediators, leukotoxin (9,lO-epoxylZoctadecenoate), plays an important role in the genesis of acute edematous lung damage in pulmonary 0, toxicity (45) . However, the exact role of the neutrophil as a primary mediator of hyperoxic lung injury is under debate. Depletion of neutrophils decreases the toxic effects of hyperoxia (46) , but neutropenia induced in rabbits by the administration of nitrogen mustard does not prevent the development of lung microvascular injury and pulmonary edema caused by exposure to hyperoxia (47) . Moreover, the presence of preexisting lung damage with accumulation of neutrophils in the lung is generally associated with decreased rather than increased sensitivity to 0, toxicity. Examples include increased 0, tolerance in animals after preexposure to sublethal doses of 0, (33) or pretreatment with Bacille de Calmette et GuCtin (BCG) (48), endotoxin (49), oleic acid (50), phosgene (51), or a-naphthylthiourea (52). These observations suggest that the neutrophil may contribute to but is not essential for the development of pulmonary 0, toxicity.
The contribution of alveolar macrophages to pathologic effects in the lung is not clear. Oxygen in vivo appears to increase the number of macrophages in sections of rat lung but may not increase the number of cells obtainable with standard methods of lung lavage (53) . It is suggested that the macrophage is responsible for the influx of neutrophils into the lung by the release of chemotactic factors under hyperoxia (54). Bacterial clearance in animal lungs in vivo decreases after exposure of animals to 100% 0, (55). Although bactericidal dysfunction of alveolar macrophages of neonatal rabbits exposed to hyperoxia has been reported (56,57), phagocytotic ability of pulmonary macrophages isolated from adult rats exposed to hyperoxia is normal (58), and the impaired bacterial clearance seen may be due to impaired mucociliary clearance (14). Production of factors such as 0, radicals and eicosanoids by alveolar macrophages probably contributes to the pathology of lung damage in hyperoxia (59,60), but such an effect has not yet been shown directly.
In the final phase, overt destruction of the capillary endothelium takes place. In rats exposed to lethal hyperoxia approximately 50% of capillary endothelial cells are destroyed in the few hours preceding the death of the animal (33). However, this destruction of endothelial cells does not result in overt lung edema; a pleural effusion, nearly equal in volume to the total lung capacity, and associated plasma volume depletion leading to respiratory or perhaps cardiovascular failure probably constitute the immediate cause of death in 0,-poisoned rats (61-64). Although the mechanism of this effusion deserves further study, the pleural effusion is the hallmark of 0, toxicity in the rat.
At time of death in rats exposed to a lethal high concentration of 0, there is no significant change in the number of type 1 or type 2 alveolar epithelial cells, even though some ultrastructural changes occur, including ruffling of the membranes of alveolar type 1 cells and blunting of the microvilli on alveolar type 2 cells. A significant epithelial cell proliferative response or frank epithelial cell destruction has not been documented (33).
In primates, including humans, there appears to be proportionately greater injury to the alveolar epithelium during the destructive phase of O2 toxicity. In monkeys, the alveolar type 1 epithelium is almost completely destroyed after 4 days in 100% 0,. Hyperplasia of type 2 alveolar epithelial cells leads to almost total replacement of the alveolar epithelial lining with type 2 cells by the seventh day of exposure (35,40).
With discontinuation of exposure to hyperoxia, or during chronic exposure to sublethal hyperoxia, at least three events may develop as a result of the exposure. The first is the proliferation of type 2 alveolar cells that appears to constitute a restructuring of the alveoli of the lung. The second is a fibroblastic proliferation that may lead to an interstitial fibrosis, one that does not seem to have any utility in recovery and may simply be a manifestation of the aberrant proliferation of a cell type (the fibroblast) that is relatively insensitive to hyperoxia (33,36). The third event is the development of pulmonary hypertension with major restructuring of the walls of large and small pulmonary arteries. Obliterative and restrictive rather than constrictive changes of the precapillary alveolar unit due to fibrosis and extension of the muscle in the microcirculation appear to be the basis for pulmonary hypertension induced by hyperoxia (65,66).
In Vitro Model Systems
In cell cultures, individual cells exposed to hyperoxia can be damaged without interaction with other cells. This is most extensively demonstrated in endothelial cells. Aortic endothelial cells show evidence of impaired uptake of serotonin after 24 h of exposure to 95% 0, (63, possibly due to decreased fluidity of the plasma membranes of these cells (68). Although endothelial cells show morphologic changes within 24 h of exposure to 80% 0, (69), increased albumin permeability of cultured endothelial monolayers becomes detectable only after exposure to 95% 0, for 3 days (70).
In addition to cell cultures, organ cultures and lung explants have been used to evaluate the effects of 0, on the lung. Ciliary activity ceases in organ cultures of tracheal epithelium after 2-6 days of exposure to 60%-80% 0, (71). The exposure of tissue slices of rat lungs to hyperoxia results in a degradation of collagen (72). Damage due to hyperoxia has also been reported in explants of parenchymal tissues from rat and rabbit lung (71,73). Release of chromium 51 indicator from labeled lung tissue in culture showed that significant cell damage occurs within 18 h of exposure to 95% 0,.
A third in vitro model, the perfused lung, has proven to be a sensitive model for detection of early functional damage to the pulmonary alveolar endothelium. Hyperoxia impairs the ability of pulmonary capillary endothelium in the perfused lung to remove various compounds, including serotonin and prostaglandins, from the pulmonary circulation (30,74, 75).
Mechanisms of Pulmonary Oxygen Toxicity Biochemistry of Oxygen Toxicity
The mechanism of O2 toxicity at the molecular level is now generally attributed to 0, free-radical reactions with cellular components. Oxygen free radicals are highly reactive 0, metabolites that have an unpaired orbital electron. The so-called "free radical theory of 0, toxicity" attributes the damaging effects of hyperoxia to these highly reactive metabolites of molecular 0,. These 0, free radicals are products of normal cellular oxidation-reduction processes. Under conditions of hyperoxia, their production increases markedly. The sources of 0, free radicals in hyperoxia are unknown but may be the accelerated oxidative processes in pulmonary parenchymal cells and phagocytes (38). The enzyme xanthine oxidase, present in endothelial cells, has also been implicated as a source of toxic 0, metabolites during hyperoxia (76,77).
The 0, molecule is normally susceptible to univalent reduction reactions in the cell to form a superoxide anion (O,-) and hydrogen peroxide (H202) (39, 78) . Although it is likely that both the superoxide anion and hydrogen peroxide have direct toxic effects, they interact to produce an even more dangerous species (79) . Figure 1 shows the Fenton reaction, which is catalyzed by metals, particularly ferrous iron, and which results in the formation of the harmless hydroxyl ion together with two extremely reactive species, the hydroxyl free radical (OH) and singlet 0, ('0,) . Although all 0, radicals are capable of various toxic activities, including lipid peroxidation, depolymerization of mucopolysaccharides, protein sulfhydryl oxidation, cross linking that can lead to enzyme inactivation, and nucleic acid damage, it seems likely that the hydroxyl free radical and singlet 0, are mainly responsible for the toxic effects of 0, (80) * Much evidence has recently appeared concerning endogenous defense systems evolved by organisms to protect their biologic integrity from destruction by free radicals. As 0, free radicals are products of normal cellular oxidative processes, a multilayered biochemical defense system exists that protects organisms against excessive free radical damage ( Figure  1 ). These biochemical defenses, which probably began evolving as soon as the first photosynthetic organisms began discharging 0, into the atmosphere, an event that can be dated to about 2 billion years ago (81), include both complex enzyme systems and low-molecular-weight free radical scavengers and are a prerequisite for aerobic life. Prototypes of these antioxidant enzymes are the metalloproteins, termed superoxide dismutases (SODS), which neutralize superoxide by conversion to hydrogen peroxide (82). Two enzymes subsequently guard against damage from hydrogen peroxide: catalase and glutathione peroxidase, both of which are capable of degradating intracellular hydrogen peroxide to water; glutathione peroxidase has a more general action and catalyzes the reduction of many hydroperoxides.
The cytoplasmic enzyme glutathione reductase participates in antioxidant defense by reforming reduced glutathione to glutathione. Glutathione, a preferential substrate for many oxidizing agents, is of primary importance in sparing protein sulfhydryl (SH) groups from oxidation.
The low-molecular-weight free radical scavengers include a-tocopherol, ascorbate, and pcarotene, a variety of molecules that preferentially partition into membranes and function by reducing lipophilic freeradical species to less toxic forms. Any molecule that reacts with a free radical can be termed "scavenger"; thus cell components such as sugars, unsaturated amino acids, sulfur-containing amino acids, and unsaturated fatty acids can also scavenge free radicals.
Role of Arachidonic Acid Metabolites
Arachidonic acid metabolites have biologic properties that can mimic the pulmonary changes produced by hyperoxic exposure. They have potent vasoactive, bronchoactive, and chemoattractant properties, and can increase vascular permeability; all of these are features of hyperoxic lung injury.
Mounting evidence suggests that reactive 0, metabolites can initiate the release and metabolism of arachidonic acid (60,8345). Increases in levels of cyclooxygenase as well as lipoxygenase pathway products in BAL fluid have been associated with hyperoxic lung injury (49,86-88), but the administration of a cyclooxygenase inhibitor to block the synthesis of prostaglandins does not result in a decrease but rather an increase in hyperoxic lung injury (49,87). The early increases in prostaglandin levels in BAL fluid that have been documented (49,86,87) , therefore, may rather reflect an overall increase in arachidonic acid metabolism, with the increase in lipoxygenase pathway products being at least as important or, perhaps, having a more primary role in mediating the hyperoxic lung injury. Recent reports show reduced mortality, inhibition of neutrophil influx, and a reduction in the increase of BAL leukotiene B4 levels in a rat hyperoxia model after treatment with the lipoxygenase inhibitor AA861 (89), and attenuation of rat and rabbit lung injury induced by hydrogen peroxide or an oxidant lipid peroxide using various leukotriene antagonists and inhibitors ( Figure 2 ). This shunting would result in increased production of lipoxygenase products and, as a consequence, increased lung injury (83,93,94). A complete understanding of this seemingly paradoxical effect of cyclooxygenase inhibitors and the role of lipoxygenase pathway products as mediators of hyperoxic lung injury awaits studies in which measurements of both prostaglandins and leukotrienes in BAL fluid can be performed and the effects of selective inhibitors can be determined.
Role of Pulmona y Surfactant
The change in lung compliance in animals exposed to high concentrations of 0, suggests involvement of the surfactant system. Although most investigators report that surface activity of the material lining the alveoli is reduced by exposure to 0, at increased partial pressures (61,9!%97), others found normal or increased surface activity, even in the presence of severe pulmonary 0, intoxication (98). Increases as well as decreases in surfactantassociated protein synthesis and decreased rates of incorporation of radiolabeled precursors into surfactant phospholipid have been reported (96,99). There are many possible reasons for such inconsistency. One is the large species and age differences in susceptibility to 0, toxicity; another is the intensity of hyperoxia used and the stage at which animals were studied. Nevertheless, it appears to be reasonably well established that the surface activity of the alveolar lining material is significantly decreased in the lungs of animals exposed to hyperoxia until death from pulmonary 0, intoxication. Whether the reduction of pulmonary surfactant function occurs as a direct toxic effect of 0, or as a consequence of other adverse effects of pulmonary 0, poisoning (for instance, inactivation of surfactant by intraalveolar 
Tolerance and Factors Influencing Tolerance to Pulmonary Oxygen Toxicity
SusceptibiIity of animals to 0,-induced lung injury varies widely among species (4), which may in part be based on differences in metabolic rate, including the degree of cytochrome P-450 inducibility (101). The response to 0, is also age-dependent: immature animals are less sensitive to 0, toxicity than adult animals (53). The increased threshold of young animals to 0, toxicity appears to be correlated with their ability to increase concentrations of protective enzymes described above in response to exposure to O2 (102) . Several constitutional and environmental factors may also influence tolerance to hyperoxia. Among factors best explored experimentally are metabolic alterations, diet, administered medications and chemicals, and prior exposure to hyperoxia or hypoxia .
Because hyperoxic damage is dependent on the rate of free-radical production by intracellular metabolic processes, factors that increase cell metabolism-such as epinephrine (103), hyperthermia (104), testosterone (105), and thyroid hormones (106)-exacerbate 0, toxicity in experimental animals and may have similar effects in humans. Dexamethasone treatment of rats exposed to hyperoxia also increases 0,-induced injury and decreases survival, but this effect seems to be dependent on the time of dexamethasone administration; if given when pulmonary inflammation due to hyperoxia is marked, dexamethasone improves survival and decreases lung damage (107).
Deficiencies of vitamins or trace metals in diets increase the susceptibility of the experimental animal to hyperoxia. The adverse effects of vitamin E and A deficiency in hyperoxic exposure have been especially well documented (52,108,109); while seleniumor copper-deficient diets also lead to increased mortality of rats under hyperoxic conditions (1 10,111).
Dietary deficiency of protein in rats potentiates toxicity to exposure to hyperoxia due to a lack of sulfur-containing amino acids, which are critical for glutathione synthesis (112). A negative nitrogen balance and deprivation of protein may make patients in the intensive care unit more susceptible to 0, toxicity. Administration of sulfur-containing amino acids may protect against this possible potentiation of lung injury.
Many compounds used therapeutically are metabolized with the production of free-radical intermedi-ates (these may be 0,-derived) and may worsen 0,-induced lung injury. A prominent example is the glycoprotein antibiotic bleomycin, which is used clinically in treatment of squamous-cell and germ-cell carcinomas. In animal models, the toxic effects of hyperoxia and bleomycin are synergistic, resulting in more extensive lung injury and fibrosis (113). Exacerbations of recognized or occult pulmonary fibrosis may also occur as a result of the therapeutic use of other antineoplastic agents (including busulfan, methotrexate, cyclophosphamide, and fortified inspired O2 concentrations) during, for example, anesthesia and in the immediate postoperative period (114,115). The mechanism of bleomycin-induced lung injury involves the formation of a DNA-bleomycinFe+, complex that has oxidaselike activity, producing a superoxide anion after binding to nuclear DNA (116,117). Disulfiram and nitrofurantoin are similarly metabolized with intermediate production of superoxide or hydroxyl radicals and 0, expectedly increases its cytotoxicity (44, 118) . Paraquat, a herbicide that occasionally causes human poisoning, is also more toxic to lungs under hyperoxic conditions (119) . Herbicides initiate plant death in a variety of ways, but in many instances they do so by overtaxing or destroying the protective mechanisms that control toxic 0, species and free radicals (120) .
To date there are no studies available on the effects of general anesthesia on pulmonary 0, toxicity apart from those in which patients have been described who showed an increased susceptibility to 02-induced lung injury after the use of fortified 0, concentrations during general anesthesia due to drug treatment or herbicide intoxication. This could be due to the fact that, generally, anesthesia procedures are too brief to induce pulmonary 0, toxicity.
The rat is capable of responding to 80%-85% 0, by increasing concentrations of SOD and the glutathione-related protective enzymes within 3-5 days of exposure (121) . Animals preexposed to a sublethal concentration of 0, are able to tolerate prolonged exposures to 100% 0,. Preadaptation of adult rats to hypoxia (10% 0, for 7 days) also results in tolerance to 0,-induced lung injury and is associated with an increase in SOD concentration (122) . On the other hand, preexposure of rats to 40%-60% 0, does not increase protective-enzyme concentrations and decreases tolerance to subsequent exposure to 100% 0, (123) . These findings suggest that almost lethal levels of superoxide radical production or cell damage are required to increase protective-enzyme concentrations by hyperoxia or hypoxia.
Therapeutic Approaches to Protection from Pulmonary Oxygen Toxicity
Many animal models of increased 0, tolerance have been investigated, but to date no clinically useful means of reducing 0,-induced lung injury in humans exists. Some experimental models will be discussed here because therapeutic measures effective in preventing or decreasing the effects of 0, toxicity, based on the results of these animal studies, may be introduced to clinical practice in the near future.
To this point, the most effective pharmacologic agent described for increasing 0, tolerance in rats is bacterial endotoxin. The protection provided by endotoxin is species-specific (rats and lambs develop 0, tolerance, but mice and hamsters do not; primates have not been tested) (109, 124, 125) . The mechanism of endotoxin protection against hyperoxic injury is not known. This improved tolerance has been associated with increases in lung SOD and other antioxidant enzymes during hyperoxic exposure (42, 123, 126) . However, the protective effect of endotoxin is blocked by acetylsalicylic acid (91) , which interferes with prostaglandin metabolism. Although production of lipoxygenase metabolites by BAL lavage cells is not inhibited by endotoxin (127) , inhibition of in vivo free-radical release by lung neutrophils has been proposed as the mechanism by which endotoxin protects rats from 0, toxicity (128) . Endotoxin treatment stimulates the production of at least three potent cytokines: tumor necrosis factorkachectin, interleukin 1, and interferon. All three factors have been implicated as playing an important role in endotoxin's protective action; pretreatment of rats with either tumor necrosis factorkachectin and interleukin 1 (129) , interferon inducers (130), or simply serum of endotoxin-protected rats (131) decreases lung injury and mortality in hyperoxia. Endotoxin also protects against hyperoxic injury to porcine endothelial cells (132) . It has been suggested that endotoxin protects these cultured endothelial cells by prevention of the hyperoxia-induced decrease in plasma membrane fluidity (133) . Currently, there is interest in the attempt to mod@ the endotoxin molecule to produce protective substances that have low inherent toxic action, so-called endotoxoids (134) .
Difficulties arise with the therapeutic use of SOD or catalase because they are intracellular enzymes with very short half-lives in plasma. There is, therefore, little scope for their use by direct intravenous injection. However, it is possible for these enzymes to enter cells if they are administered in liposomes, and their plasma half-life may also be extended by conjugation with polyethylene glycol. Experimental use of SOD and catalase in these forms results in a substantial protection (135139). Polyethylene glycol conjugation with antioxidants may be more effective than liposome encapsulation (140). Delivery of antioxidants conjugated to polyethylene glycol is improved and their half-lives prolonged compared with liposome encapsulation.
Instillation of exogenous surfactant in rabbits exposed to 100% 0, for 64 h prevents the development of abnormal lung mechanics and alveolar collapse and mitigates the degree of lung edema, once animals are returned to room air; at least part of this beneficial effect appears to be related to the action of exogenous surfactant in preventing an increase in alveolar surface tension (141).
The leukotriene synthesis blocker AA861 significantly reduces mortality of rats caused by O2 toxicity when administered intraperitoneally (89). AA861 inhibits leukotriene B, production, a chemotactic agent for neutrophils, and thus AA861 would reduce the accumulation of neutrophils in the lung. Intact erythrocytes placed in the tracheobroncheal tree of hyperoxic rats dramatically improves their chances for survival (142) . Lungs from erythrocyteprotected rats show almost none of the morphologic damage suffered by untreated animals. These protective effects of insufflated erythrocytes would be based on their recyclable glutathione. An ironic connotation of these experiments is that small amounts of spontaneous alveolar hemorrhage, a common feature in respiratory distress situations, may actually be beneficial in patients ventilated with 0, at high inspired tensions.
Continuous infusion of the sulfhydryl compounds cysteamine or N-acetylcysteine in rats exposed to 100% 0, results in a reduced mortality and lung edema caused by hyperoxia (143). As sulfhydryl compounds are among the most important endogenous antioxidant agents, administration of these cellpermeable sulfhydryl compounds probably prevents the oxidation of lung nonprotein sulfhydryls such as glutathione (144) .
Desferioxamine is an iron-chelating agent that may prove to have a therapeutic role, as ferrous iron is both a potent source of electrons for conversion to the superoxide anion and a catalyst in the Fenton reaction. In rats, the administration of desferioxamine provides partial protection against hyperoxic lung damage (145).
Pretreatment of rats by inducers of pulmonary cytochrome P-450 results in a marked protection against pulmonary 0, toxicity. This protection is associated with a substantial increase in the components of the pulmonary cytochrome P-450 system, its peroxidase activity, and an increased response to hyperoxia by lung antioxidant enzyme activities (146) .
Although dietary supplementation of vitamins, proteins, and trace metals provides only partial protection in animals with a deficiency of these factors, dietary supplementation of polyunsaturated fatty acids in newborn rats results in increased lung polyunsaturated fatty acid content and improved hyperoxic survival (147). How lung lipid composition works to influence tolerance to pulmonary 0, toxicity is not yet known.
Conclusion
The last 25 yr have seen major progress in our understanding of the mechanisms and pathophysiology of pulmonary O2 toxicity and, in particular, the elucidation of the role of free radicals. Important problems that remain include methods for early detection of hyperoxic damage and the means to augment antioxidant defenses. With the solution of these problems it should be possible to expand significantly the value and indications for the therapeutic use of 02.
